Onconova Therapeutics (ONTX) Upgraded by Zacks Investment Research to "Buy"
They currently have $0.50 price objective on the biopharmaceutical company's stock. According to Zacks, "Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company.
Start the conversation, or Read more at Daily Political.
Add your comments below
|a 70's murder in Bensalem ... was anybody aroun... (Feb '06)||Aug '18||thomasina||254|
|Local Boy Scouts visit Gettysburg National Mili...||May '18||Steve Gratmen||1|
|Best Local Mortgage Company||May '18||andrewscott||1|
|Looking for owners of Creative Photography and ... (Jan '13)||Mar '18||not a Raab||5|
|Lawsuit claims rodent was baked into Chick-fil-... (Aug '17)||Aug '17||Ted Haggard s Gos...||2|
|Chambersburg Public Opinion (Jan '08)||Feb '17||martz||5|
|Trump to be in Newtown, Bucks County, Friday night (Oct '16)||Oct '16||Jason||1|
Find what you want!
Search Newtown Forum Now
Copyright © 2018 Topix LLC